Article

Analogues of the dopamine D2 receptor antagonist L741,626: Binding, function, and SAR.

Medicinal Chemistry, National Institute on Drug Abuse-Intramural Research Program, National Institutes of Health, 5500 Nathan Shock Drive, Baltimore, MD 21224, USA.
Bioorganic & Medicinal Chemistry Letters (Impact Factor: 2.34). 03/2007; 17(3):745-9. DOI: 10.1016/j.bmcl.2006.10.076
Source: PubMed

ABSTRACT A series of analogues of the dopamine D2 receptor antagonist L741,626 were synthesized and evaluated for binding and function at D2 family receptor subtypes. Several analogues showed comparable binding profiles to the parent ligand, however, in general, chemical modification served to reduce D2 binding affinity and selectivity.

1 Bookmark
 · 
125 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Microwave irradiation under solvent-free conditions induces 1-acetyl-4-styrylpyrazoles to undergo Diels–Alder cycloaddition reactions with N-methyl- or N-phenylmaleimide to give tetrahydroindazoles in good yields and with high selectivities. With conventional heating, these reactions either do not occur or afford only traces of the cycloadducts. These cycloadducts were then converted into the corresponding 1H-indazoles by dehydrogenation with DDQ in dry 1,2,4-trichlorobenzene under microwave irradiation or classical heating conditions. The structures of all new derivatives and the stereochemistries of the cycloadducts were assigned by NMR spectroscopy. (© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2009)
    Annalen der Chemie und Pharmacie 07/2009; 2009(26):4468 - 4479. · 3.10 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Indazoles are of considerable interest due to the broad variety of their biological activities. This overview summarizes structures of pharmacologically interesting indazoles published during the last decade, as well as syntheses, reactions, and functionalizations. Recent advances in the chemistry of N-heterocyclic carbenes of indazole (indazol-3-ylidenes) and indazolium salts are also reported.(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2008)
    Annalen der Chemie und Pharmacie 05/2008; 2008(24):4073 - 4095. · 3.10 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The contribution of dopamine receptor subtypes in mediating the discriminative stimulus effects of cocaine is not fully established. Many drug discrimination studies use food to maintain responding, necessitating food restriction, which can alter drug effects. This study established stimulus control with cocaine (10 mg/kg) in free-feeding and food-restricted rats responding under a schedule of stimulus shock termination (SST) and in food-restricted rats responding under a schedule of food presentation to examine whether feeding condition or the reinforcer used to maintain responding impacts the effects of cocaine. Dopamine receptor agonists and antagonists were examined for their ability to mimic or attenuate, respectively, the effects of cocaine. Apomorphine, quinpirole, and lisuride occasioned >90 % responding on the cocaine-associated lever in free-feeding rats responding under a schedule of SST; apomorphine, but not quinpirole or lisuride, occasioned >90 % responding on the cocaine lever in food-restricted rats responding under a schedule of SST. In food-restricted rats responding for food these drugs occasioned little cocaine lever responding and were comparatively more potent in decreasing responding. In free-feeding rats, the effects of cocaine were attenuated by the D2/D3 receptor antagonist raclopride and the D3 receptor-selective antagonist PG01037. In food-restricted rats, raclopride and the D2 receptor-selective antagonist L-741,626 attenuated the effects of cocaine. Raclopride antagonized quinpirole in all groups while PG01037 antagonized quinpirole only in free-feeding rats. These results demonstrate significant differences in the discriminative stimulus of cocaine that are due to feeding conditions and not to the use of different reinforcers across procedures.
    Psychopharmacology 09/2013; · 4.06 Impact Factor

Full-text (3 Sources)

Download
35 Downloads
Available from
Jun 1, 2014